Molecular Analysis for Personalised Therapy Congress 2020

Amsterdam, Netherlands - 08 Oct - 10 Oct 2020

MAP is the leading congress in precision medicine in oncology in Europe, established by key opinion leaders in the field.

By attending MAP, participants will learn how to integrate insights from tumour sample analysis into daily practice, how to seek and identify actionable mutations in patient DNA and how to provide the best possible personalised treatment. 

Founded by Jean-Charles Soria, Fabrice André and Charles Swanton, the MAP Congress has established itself as a point of reference for all specialists willing to create a bright future for precision medicine in oncology, by delivering a highly specific, minimally toxic and dramatically effective treatment for each patient. 

The MAP Congress is the result of a close partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, which are all committed to offer the best care to people with cancer, nationally and worldwide, through oncology education and research.

We look forward to seeing you at MAP 2020 in Amsterdam!

Venue

The Congress will take place at the Amsterdam Conference Centre Beurs van Berlage, Damrak 243, Amsterdam

Organisation

MAP Congress Team
c/o ESMO Head Office
Via Ginevra 4
6900 Lugano
Switzerland
map@esmo.org